4

6)

o

@

@
a

ao
ay

a2
a3)
ay

as)
as)
an

Allotment of 38,434 Series A CGPS to PI Opportunities Fund ~ I a category II alternative investment fund registered under Securities and
Exchange Board of India (Alternative Investment Funds) Regulations, 2012, represented by its trustee Hasham Premji Private Limited

Allotment of 2,767,240 Series A CCPS to PI Opportunities Fund ~ I, a category II alternative investment fund registered under Securities
and Exchange Board of India (Alternative Investment Funds) Regulations, 2012, represented by its trustee Hasham Premji Private Limited

Allotment of 14,182,105 Equity Shares to PI Opportunities Fund ~ I, a category I alternative investment fund registered under Securities
and Exchange Board of India (Alternative Investment Funds) Regulations, 2012, represented by its trustee Hasham Premji Private Limited
upon conversion of 2,836,421 Series A CCPS held by it

Allotment of 2,995,200 Series B CCPS to Gangadi Madhukar Reddy, 870,560 Series B CCPS to Gangadi Madhukar Reddy (as trustee of
MedPlus Employee Benefit Trust), 360,000 Series B CCPS to Pravesa Holdings Private Limited, 52,400 Series B CCPS to A Raghava Reddy,
17,720 Series B CCPS to PVS Raju, 32,760 Series B CCPS to Vivek Mundra (HUF), 18,920 Series B CCPS to J. Kondal Rayudu, 32,320
Series B CCPS to Ajay Kumar Bannai, 38,240 Series B CCPS to Surendranath Mantena, 18,000 Series B CCPS to Uma Kuman Nanduri,
18,000 Series B CCPS to Jayalakshmi Puppala, 15,120 Series B CPS to Suneel Dhawan, 7,560 Series B CCPS to Navdeep Patyal, 7,560
Series B CCPS to Ashok Mayya, 5,840 Series B CCPS to R. Venkata Reddy, 18,200 Series B CCPS to P Rajya Lakshmi, 20,720 Series B
CCPS to K. Prakurthi, 15,760 Series B CCPS to Sangeeta Raju, 1,919,960 Series B CCPS to Pl Opportunities Fund-1, 361,080 Series B
CCPS to S. S. Pharma LLC, 107,920 Series B CCPS to Shore Pharma, 88,040 Series B CCPS to Natco Pharma, 87,920 Series B CCPS to
Time Cap Pharma, 4,960 Series B CCPS to TK Kurien, 4520 Series B CCPS to Nithya Venkataramam, 4520 Series B CPS to Atul Gupta,
4520 Series B CCPS to Rahul Garg, 4520 Series B CCPS to Manoj Jaiswal, 1800 Series B CCPS to Kollengode Ramanathan
Lakshminarayana, 1800 Series B CCPS to Bijou Kurien, 920 Series B CCPS to Ikram Noor Jaffer, 920 Series B CCPS to Ajitesh Murali
Nair, and 4,813,400 Series B CCPS to Lavender Rose Investment Ltd

Allotment of 14,976,000 Equity Shares to Gangadi Madhukar Reddy upon conversion of 2,995,200 preference shares of ®20 held by it

Allotment of 466,400 Equity Shares to T Srinivas Reddy (As trustee of MedPlus Employees Benefit Fund) upon conversion of 93,280 Series
BCCPS, 1,800,000 Equity Shares to Pravesa Holdings Private Limited upon conversion of 360,000 Series B CCPS, 262,000 Equity Shares
to A Raghava Reddy upon conversion of 52,400 Series. B CCPS, 88,600 Equity Shares to PVS Raju upon conversion of 17,720 Series B
CCP, 163,800 Equity Shares to Vivek Mundra (HUF) upon conversion of 32,760 Series B CCPS, 94,600 Equity Shares to J. Kondal Rayudu
upon conversion of 18,920 Series B CCPS, 161,600 Equity Shares to Ajay Kumar Bannai upon conversion of 32,320 Series B CCPS, 866,200
Equity Shares to Surendranath Mantena upon conversion of 173,240 Series B CCPS, 90,000 Equity Shares to Uma Kumari Nanduri upon
conversion of 18,000 Series B CCPS, 90,000 Equity Shares to Jayalakshmi Puppala upon conversion of 18,000 Series B CCPS, 75,600 Equity
Shares to Suneel Dhawan upon conversion of 15,120 Series B CCPS, 37,800 Equity Shares to Navdeep Patyal upon conversion of 7,560
Series B CCPS, 37,800 Equity Shares to Ashok Mayya upon conversion of 7,560 Series B CCPS, 29,200 Equity Shares to R. Venkat Reddy
upon conversion of 5,840 Series B CCPS, 91,000 Equity Shares to P Rajya Lakshmi upon conversion of 18,200 Series B CCPS, 103,600
Equity Shares to K Prakurthi upon conversion of 20,720 Series B CCPS, 78,800 Equity Shares to Sangeeta Raju upon conversion of 15,760
Series B CCPS, 9,599,800 Equity Shares to PI Opportunities Fund-I upon conversion of 1,919,960 Series B CCPS, 1,805,400 Equity Shares
to SS Pharma LLC upon conversion of 361,080 Series B CCPS, 5,39,600 Equity Shares to Shore Pharma LLC upon conversion of 107,920
Series B CCPS, 440,200 Equity Shares to Natco Pharma Limited upon conversion of 88,040 Series B CCPS, 4,39,600 Equity Shares to Time
Cap Pharma Labs Limited upon conversion of 87,920 Series B CCPS, 24,800 Equity Shares to TK Kurein upon conversion of 4,960 Series
BCCPS, 22,600 Equity Shares to Nithya Venkataramani upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Atul Gupta upon
conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Rahul Garg upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to
Manoj Jaiswal upon conversion of 4,520 Series B CCPS, 9,000 Equity Shares to Kollengode Ramanathan Lakshminarayana upon conversion
of 1,800 Series B CCPS, 9,000 Equity Shares to Bijou Kurein upon conversion of 1,800 Series B CCPS, 4,600 Equity Shares to Ikram Noor
Jaffer upon conversion of 920 Series B CCPS, 4,600 Equity Shares to Ajitesh Murali Nair upon conversion of 920 Series B CCPS, 24,067,000
Equity Shares to Lavender Rose Investment Ltd upon conversion of 4,813,400 Series B CCPS, 1,327,000 Equity Shares to Bhaskar Reddy
Cherukupalli upon conversion of 265,400 Series B CCPS, 2,70,000 Equity Shares to Paidiwar Srinivas upon conversion of 54,000 Series B
CPS, 270,000 Equity Shares to Pradeep Yalamandala upon conversion of 54,000 Series B CCPS, 180,000 Equity Shares to Phani Srinivas
Ramella upon conversion of 36,000 Series B CCPS, 1,35,000 Equity Shares to Brundaban Dash upon conversion of 27,000 Series B CCPS,
1,35,000 Equity Shares to Satya Murali Krishna Kammila upon conversion of 27,000 Series B CPS, 1,35,000 Equity Shares to Kandasamy
Vairaperumal upon conversion of 27,000 Series B CCPS, 90,000 Equity Shares to Venugopal Siripuram upon conversion of 18,000 Series B
CCP, 67,600 Equity Shares to Prabhakarreddy Gndlapalli upon conversion of 13,520 Series B CCPS, 45,000 Equity Shares to Tadi
Srinivasa Reddy upon conversion of 9,000 Series B CCPS, 45,000 Equity Shares to Paramesham Kasturi upon conversion of 9,000 Series B
CCP, 45,000 Equity Shares to Prasad Reddy Battinapatla upon conversion of 9,000 Series B CCPS, 33,800 Equity Shares to Ravi Kumar
Kodali upon conversion of 6,760 Series B CCPS, 33,800 Equity Shares to Devaraj Goud Bakki upon conversion of 6,760 Series B CCPS,
33,800 Equity Shares to Tubati Venkata Satyanarayana upon conversion of 6,760 Series B CCPS, 33,800 Equity Shares to Siba Narayan
Mishra upon conversion of 6,760 Series B CCPS, 33,800 Equity Shares to Tapan Majumdar upon conversion of 6,760 Series B CCPS, 33,800
Equity Shares to Subba Rao Madhavaram upon conversion of 6,760 Series B CCPS, 24,800 Equity Shares to Guntakandla Raja Shekhara
Reddy upon conversion of 4,960 Series B CCPS, 22,600 Equity Shares to Sathish Prashanth Kumar upon conversion of 4,520 Series B CCPS,
22,600 Equity Shares to Atul Dnyaneshwarrao Sawarkar upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Reddy
Kattamanchi Umapathi upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Kalava Raghunadha Reddy upon conversion of
4,520 Series B CCPS, 22,600 Equity Shares to Kula Sekhar Puvvada upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to
Suguneswar Namala upon conversion of 4,520 Series B CCPS, 18,000 Equity Shares to Sampath Kumar Chepuri upon conversion of 3,600
Series B CCPS, 15,800 Equity Shares to Raja Gopal Manchiraju upon conversion of 3,160 Series B CCPS, 15,800 Equity Shares to Venkat
Rao Rangineni upon conversion of 3,160 Series B CCPS, 11,200 Equity Shares to Rama Naga Srinivas Dasari upon conversion of 2,240
Series B CCPS, 11,200 Equity Shares to Narsimha Reddy Atla upon conversion of 2,240 Series B CCPS, 11,200 Equity Shares to Raju
Guntuka upon conversion of 2,240 Series B CPS, 9,000 Equity Shares to Srinivasa Rao Penumudi upon conversion of 1,800 Series B CCPS,
6,800 Equity Shares to Jajula Venkata Satyanarayana upon conversion of 1,360 Series B CCPS, and 4,600 Equity Shares to Mohammad
Zafarshah Khadari upon conversion of 920 Series B CCPS.

Allotment of 3,053,560 Series B1 CCPS to Agilemed Investments Private Limited

Allotment of 6,660,575 Equity Shares to Agilemed Investments Private Limited upon conversion of 1,332,115 preference shares of ®20 held
byit

Allotment of 8,607,225 Equity Shares to Agilemed Investments Private Limited upon conversion of 1,721,445 Series B1 CCPS

Allotment of 3,331,120 Series B2 CCPS to Lone Furrow Investments Private Limited

Allotment of 8,273,510 Equity Shares to Lone Furrow Investments Private Limited upon conversion of 1,654,702 preference shares of %20
held by it

Allotment of 8,543,340 Equity Shares to Lone Furrow Investments Private Limited upon conversion of 1,676,418 Series B2 CCPS
Allotment of 5,60,896 Series Cl CGPS to Lavender Rose Investment Ltd
Allotment of 28,04,480 Equity Shares to Lavender Rose Investment Ltd upon conversion of 560,896 Series C1 CCPS

80
